The Mediterranean diet: Effects on proteins that mediate fatty acid metabolism in the colon

Nutrition Reviews

Volumn 69, Issue 12, 2011, Pages 730-744

  Djuric, Zora ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Dietary intervention; Fatty acids; Inflammation; Mediterranean diet; Proteomics

Indexed keywords

ACYL COENZYME A DESATURASE; ARACHIDONIC ACID; CYCLOOXYGENASE 2; FATTY ACID; FATTY ACID BINDING PROTEIN; ICOSANOID; ICOSAPENTAENOIC ACID; LEUKOTRIENE; LINOLEIC ACID; LIPOXYGENASE; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTAGLANDIN SYNTHASE; PROTEOME;

CANCER PREVENTION; CANCER RISK; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; DIETARY INTAKE; ENZYME ACTIVITY; FATTY ACID METABOLISM; FOOD INTAKE; HUMAN; MEDITERRANEAN DIET; NONHUMAN; PATIENT COUNSELING; PROSTAGLANDIN SYNTHESIS; PROTEOMICS; REVIEW;

COLON; COLONIC NEOPLASMS; DIET, MEDITERRANEAN; DIETARY FATS; EICOSANOIDS; FATTY ACIDS; HUMANS; LIPOXYGENASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 82955246105     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2011.00439.x     Document Type: Review

References (201)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 1997.
2. Fung TT, Hu FB, Wu K, Chiuve SE, Fuchs CS, Giovannucci E. The Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets and colorectal cancer. Am J Clin Nutr. 2010;92:1429-1435.
3. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92:1189-1196.
4. Gallus S, Bosetti C, La Vecchia C. Mediterranean diet and cancer risk. Eur J Cancer Prev. 2004;13:447-452.
5. English DR, MacInnis RJ, Hodge AM, Hopper JL, Haydon AM, Giles GG. Red meat, chicken, and fish consumption and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:1509-1514.
6. La Vecchia C. Mediterranean diet and cancer. Public Health Nutr. 2004;7:965-968.
7. Kojima M, Wakai K, Tokudome S, etal. Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: a prospective study. Am J Epidemiol. 2005;161:462-471.
8. Cottet V, Bonithon-Kopp C, Kronborg O, etal. Dietary patterns and the risk of colorectal adenoma recurrence in a European intervention trial. Eur J Cancer Prev. 2005;14:21-29.
9. Kesse E, Clavel-Chapelon F, Boutron-Ruault MC. Dietary patterns and risk of colorectal tumors: a cohort of French women of the National Education System (E3N). Am J Epidemiol. 2006;164:1085-1093.
10. Verberne L, Bach-Faig A, Buckland G, Serra-Majem L. Association between the Mediterranean diet and cancer risk: a review of observational studies. Nutr Cancer. 2010;62:860-870.
11. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, MA: Harvard University Press; 1980.
12. Panagiotakos D, Kalogeropoulos N, Pitsavos C, etal. Validation of the MedDietScore via the determination of plasma fatty acids. Int J Food Sci Nutr. 2009;60(Suppl 5):168-180.
13. Trichopoulou A, Bamia C, Trichopoulos D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ. 2009;338:b2337.
14. Beunza JJ, Toledo E, Hu FB, etal. Adherence to the Mediterranean diet, long-term weight change, and incident overweight or obesity: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr. 2010;92:1484-1493.
15. Backlund MG, Mann JR, Dubois RN. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2. Oncology. 2005;69(Suppl 1):28-32.
16. American Cancer Society. Colorectal Cancer Facts and Figures - Special Edition 2005. Atlanta, GA: American Cancer Society; 2005.
17. Schottenfeld D, Fraumeni JF Jr. Cancer Epidemiology and Prevention, 2nd ed. New York: Oxford; 1996.
18. McMichael AJ, McCall MG, Hartshorne JM, Woodings TL. Patterns of gastro-intestinal cancer in European migrants to Australia: the role of dietary change. Int J Cancer. 1980;25:431-437.
19. Paspatis GA, Papanikolaou N, Zois E, Michalodimitrakis E. Prevalence of polyps and diverticulosis of the large bowel in the Cretan population. An autopsy study. Int J Colorectal Dis. 2001;16:257-261.
20. Simopoulos AP. The traditional diet of Greece and cancer. Eur J Cancer Prev. 2004;13:219-230.
21. Frenandez E, Vecchia CL, Gonzales JR, Lucchini F, Negri E, Levi F. Coverging patterns of colorectal cancer mortality in Europe. Eur J Cancer. 2005;41:430-437.
22. Mai V, Kant AK, Flood A, Lacey JV Jr, Schairer C, Schatzkin A. Diet quality and subsequent cancer incidence and mortality in a prospective cohort of women. Int J Epidemiol. 2005;34:54-60.
23. Koushik A, Hunter DJ, Spiegelman D, etal. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst. 2007;99:1471-1483.
24. Martinez-Gonzalez MA, Estruch R. Mediterranean diet, antioxidants and cancer: the need for randomized trials. Eur J Cancer Prev. 2004;13:327-335.
25. Kant AK, Schatzkin A, Graubard BI, Schairer C. A prospective study of diet quality and mortality in women. JAMA. 2000;283:2109-2115.
26. Gerber MJ, Scali JD, Michaud A, etal. Profiles of a healthful diet and its relationship to biomarkers in a population sample from Mediterranean southern France. J Am Diet Assoc. 2000;100:1164-1171.
27. Hoffmann I. Transcending reductionism in nutrition research. Am J Clin Nutr. 2003;78:S514-S516.
28. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599-2608.
29. Dixon LB, Subar AF, Peters U, etal. Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma. J Nutr. 2007;137:2443-2450.
30. Reedy J, Mitrou PN, Krebs-Smith SM, etal. Index-based dietary patterns and risk of colorectal cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol. 2008;168:38-48.
31. Mitrou PN, Kipnis V, Thiebaut AC, etal. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med. 2007;167:2461-2468.
32. Peters U, Sinha R, Chatterjee N, etal. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet. 2003;361:1491-1495.
33. Bingham SA, Day NE, Luben R, etal. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003;361:1496-1501.
34. Alberts DS, Einspahr J, Ritenbaugh C, etal. The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps. Cancer Epidemiol Biomarkers Prev. 1997;6:161-169.
35. Sonoshita M, Takaku K, Oshima M, Sugihara K-I, Taketo MM. Cycloogenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res. 2002;62:6846-6849.
36. Takeda H, Sonoshita M, Oshima H, etal. Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis. Cancer Res. 2003;63:4872-4877.
37. Kargman SL, O'Neil GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 1995;55:2556-2559.
38. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107:1183-1188.
39. Sano H, Kawahito Y, Wilder RL. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 1995;55:3785-3789.
40. Chan TA. Cyclooxygenase inhibition and mechanisms of colorectal cancer prevention. Curr Cancer Drug Targets. 2003;3:455-463.
41. Kitamura T, Itoh M, Noda T, Matsuura M, Wakabayashi K. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Int J Cancer. 2004;109:576-580.
42. Rothwell PM, Wilson M, Elwin CE, etal. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376:1741-1750.
43. Sanderson P, Johnson IT, Mathers JC, etal. Emerging diet-related surrogate end points for colorectal cancer: UK Food Standards Agency diet and colonic health workshop report. Br J Nutr. 2004;91:315-323.
44. Frommel TO, Dyavanapalli M, Oldham T, etal. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients. Clin Cancer Res. 1997;3:209-213.
45. Smalley WE, DuBois RN. Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol. 1997;39:1-20.
46. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res. 1997;57:3465-3470.
47. Broughton KS, Wade JW. Total fat and (n-3):(n-6) fat ratios influence eicosanoid production in mice. J Nutr. 2002;132:88-94.
48. Mooney MA, Vaughn DM, Reinhart GA, etal. Evaluation of the effects of omega-3 fatty acid-containing diets on the inflammatory stage of wound healing in dogs. Am J Vet Res. 1998;59:859-863.
49. Boudreau MD, Chanmugam PS, Hart SB, Lee SH, Hwang DH. Lack of dose response by dietary n-3 fatty acids at a constant ratio of n-3 to n-6 fatty acids in suppressing eicosanoid biosynthesis from arachidonic acid. Am J Clin Nutr. 1991;54:111-117.
50. Bartoli R, Fernandez-Banares F, Navarro E, etal. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut. 2000;46:191-199.
51. Schroeder F, Petrescu AD, Huang H, etal. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids. 2008;43:1-17.
52. Richieri GV, Ogata RT, Zimmerman AW, Veerkamp JH, Kleinfeld AM. Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry. 2000;39:7197-7204.
53. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7:489-503.
54. Pelsers MM, Namiot Z, Kisielewski W, etal. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem. 2003;36:529-535.
55. Levy E, Menard D, Delvin E, etal. Localization, function and regulation of the two intestinal fatty acid-binding protein types. Histochem Cell Biol. 2009;132:351-367.
56. Lenaerts K, Bouwman FG, Lamers WH, Renes J, Mariman EC. Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics. 2007;8:91.
57. Sweetser DA, Birkenmeier EH, Klisak IJ, etal. The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J Biol Chem. 1987;262:16060-16071.
58. Thumser AE, Storch J. Liver and intestinal fatty acid-binding proteins obtain fatty acids from phospholipid membranes by different mechanisms. J Lipid Res. 2000;41:647-656.
59. Zimmerman AW, Veerkamp JH. New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci. 2002;59:1096-1116.
60. Yamazaki T, Kanda T, Sakai Y, Hatakeyama K. Liver fatty acid-binding protein is a new prognostic factor for hepatic resection of colorectal cancer metastases. J Surg Oncol. 1999;72:83-87.
61. Adachi M, Kurotani R, Morimura K, etal. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut. 2006;55:1104-1113.
62. Coe NR, Bernlohr DA. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta. 1998;1391:287-306.
63. Zimmer JS, Dyckes DF, Bernlohr DA, Murphy RC. Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products. J Lipid Res. 2004;45:2138-2144.
64. Makowski L, Hotamisligil GS. Fatty acid binding proteins - the evolutionary crossroads of inflammatory and metabolic responses. J Nutr. 2004;134:S2464-S2468.
65. Shen J, Pavone A, Mikulec C, etal. Protein expression profiles in the epidermis of cyclooxygenase-2 transgenic mice by 2-dimensional gel electrophoresis and mass spectrometry. J Proteome Res. 2007;6:273-286.
66. Chapkin RS, Clark AE, Davidson LA, Schroeder F, Zoran DL, Lupton JR. Dietary fiber differentially alters cellular fatty acid-binding protein expression in exfoliated colonocytes during tumor development. Nutr Cancer. 1998;32:107-112.
67. Xiao R, Badger TM, Simmen FA. Dietary exposure to soy or whey proteins alters colonic global gene expression profiles during rat colon tumorigenesis. Mol Cancer. 2005;4:1.
68. Poirier H, Niot I, Degrace P, Monnot MC, Bernard A, Besnard P. Fatty acid regulation of fatty acid-binding protein expression in the small intestine. Am J Physiol. 1997;273:G289-G295.
69. Clarke SD, Armstrong MK. Cellular lipid binding proteins: expression, function, and nutritional regulation. FASEB J. 1989;3:2480-2487.
70. Alpers DH, Bass NM, Engle MJ, DeSchryver-Kecskemeti K. Intestinal fatty acid binding protein may favor differential apical fatty acid binding in the intestine. Biochim Biophys Acta. 2000;1483:352-362.
71. Marin C, Perez-Jimenez F, Gomez P, etal. The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am J Clin Nutr. 2005;82:196-200.
72. Morcillo S, Rojo-Martinez G, Cardona F, etal. Effect of the interaction between the fatty acid binding protein 2 gene Ala54Thr polymorphism and dietary fatty acids on peripheral insulin sensitivity: a cross-sectional study. Am J Clin Nutr. 2007;86:1232-1237.
73. Okada T, Sato NF, Kuromori Y, etal. Thr-encoding allele homozygosity at codon 54 of FABP 2 gene may be associated with impaired delta 6 desaturase activity and reduced plasma arachidonic acid in obese children. J Atheroscler Thromb. 2006;13:192-196.
74. Goodridge AG. Regulation of the gene for fatty acid synthase. Fed Proc. 1986;45:2399-2405.
75. Rashid A, Pizer ES, Moga M, etal. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol. 1997;150:201-208.
76. Hashimoto T, Kusakabe T, Watanabe K, etal. Liver-type fatty acid-binding protein is highly expressed in intestinal metaplasia and in a subset of carcinomas of the stomach without association with the fatty acid synthase status in the carcinoma. Pathobiology. 2004;71:115-122.
77. Ogino S, Nosho K, Meyerhardt JA, etal. Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol. 2008;26:5713-5720.
78. Menendez JA, Vazquez-Martin A, Ortega FJ, Fernandez-Real JM. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem. 2009;55:425-438.
79. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763-777.
80. Pan MH, Lin CC, Lin JK, Chen WJ. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. J Agric Food Chem. 2007;55:5030-5037.
81. Xiao R, Su Y, Simmen RC, Simmen FA. Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase. Am J Physiol Gastrointest Liver Physiol. 2008;294:G868-G876.
82. Zhao WH, Gao C, Zhang YX, Tian WX. Evaluation of the inhibitory activities of aceraceous plants on fatty acid synthase. J Enzyme Inhib Med Chem. 2007;22:501-510.
83. Menendez JA, Lupu R. Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9). Curr Pharm Biotechnol. 2006;7:495-502.
84. Dias VC, Parsons HG. Modulation in delta 9, delta 6, and delta 5 fatty acid desaturase activity in the human intestinal CaCo-2 cell line. J Lipid Res. 1995;36:552-563.
85. Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Int J Oncol. 2004;24:1369-1383.
86. Natali F, Siculella L, Salvati S, Gnoni GV. Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells. J Lipid Res. 2007;48:1966-1975.
87. Kearney KE, Pretlow TG, Pretlow TP. Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention. Int J Cancer. 2009;125:249-252.
88. Algire C, Amrein L, Zakikhani M, Panasci L, Pollak M. Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocr Relat Cancer. 2010;17:351-360.
89. Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr. 2001;131:1129-1132.
90. U.S. Department of Agriculture, Agricultural Research Service. Nutrient intakes from food: mean amounts consumed per individual, by gender and age. In: What We Eat in America. 2010:NHANES 2007-2008. Available at.
91. Raatz SK, Bibus D, Thomas W, Kris-Etherton P. Total fat intake modifies plasma fatty acid composition in humans. J Nutr. 2001;131:231-234.
92. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999;83:217-244.
93. Green CD, Ozguden-Akkoc CG, Wang Y, Jump DB, Olson LK. Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species. J Lipid Res. 2010;51:1871-1877.
94. Guillou H, Zadravec D, Martin PG, Jacobsson A. The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice. Prog Lipid Res. 2010;49:186-199.
95. Tikhonenko M, Lydic TA, Wang Y, etal. Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes. 2010;59:219-227.
96. Hansen-Petrik MB, McEntee MF, Johnson BT, etal. Selective inhibition of delta-6 desaturase impedes intestinal tumorigenesis. Cancer Lett. 2002;175:157-163.
97. Accioly MT, Pacheco P, Maya-Monteiro CM, etal. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res. 2008;68:1732-1740.
98. Mangravite LM, Dawson K, Davis RR, Gregg JP, Krauss RM. Fatty acid desaturase regulation in adipose tissue by dietary composition is independent of weight loss and is correlated with the plasma triacylglycerol response. Am J Clin Nutr. 2007;86:759-767.
99. Pan DA, Hulbert AJ, Storlien LH. Dietary fats, membrane phospholipids and obesity. J Nutr. 1994;124:1555-1565.
100. Lands WE, Libelt B, Morris A, etal. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta. 1992;1180:147-162.
101. Tu WC, Cook-Johnson RJ, James MJ, Muhlhausler BS, Gibson RA. Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression. Prostaglandins Leukot Essent Fatty Acids. 2010;83:61-68.
102. Ouyang P, Jiang Y, Doan HM, etal. Weight loss via exercise with controlled dietary intake may affect phospholipid profile for cancer prevention in murine skin tissues. Cancer Prev Res (Phila). 2010;3:466-477.
103. Wang Y, Botolin D, Christian B, Busik J, Xu J, Jump DB. Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J Lipid Res. 2005;46:706-715.
104. Shimamura K, Nagumo A, Miyamoto Y, etal. Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6. Eur J Pharmacol. 2010;630:34-41.
105. Triggiani M, Oriente A, Marone G. Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. J Immunol. 1994;152:1394-1403.
106. Yu W, Bozza PT, Tzizik DM, etal. Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies. Am J Pathol. 1998;152:759-769.
107. Murakami M, Kambe T, Shimbara S, Kudo I. Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J Biol Chem. 1999;274:3103-3115.
108. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-182.
109. Osterstrom A, Dimberg J, Fransen K, Soderkvist P. Expression of cytosolic and group X secretory phospholipase A(2) genes in human colorectal adenocarcinomas. Cancer Lett. 2002;182:175-182.
110. Brock TG, Peters-Golden M. Activation and regulation of cellular eicosanoid biosynthesis. Sci World J. 2007;7:1273-1284.
111. Dennis EA. Phospholipase A2 in eicosanoid generation. Am J Respir Crit Care Med. 2000;161:S32-S35.
112. Pruzanski W, Vadas P, Browning J. Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes. J Lipid Mediat. 1993;8:161-167.
113. Fijneman RJ, Cormier RT. The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine. Front Biosci. 2008;13:4144-4174.
114. Kennedy BP, Soravia C, Moffat J, etal. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res. 1998;58:500-503.
115. Wendum D, Svrcek M, Rigau V, etal. COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas. Mod Pathol. 2003;16:130-136.
116. Lagorce-Pages C, Paraf F, Wendum D, Martin A, Flejou JF. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus. Virchows Arch. 2004;444:426-435.
117. Dimberg J, Samuelsson A, Hugander A, Soderkvist P. Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer. Anticancer Res. 1998;18:3283-3287.
118. Ilsley JN, Nakanishi M, Flynn C, etal. Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res. 2005;65:2636-2643.
119. Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut. 1994;35:1593-1598.
120. Kuratko CN, Pence BC. Dietary lipid and iron modify normal colonic mucosa without affecting phospholipase A2 activity. Cancer Lett. 1995;95:181-187.
121. Rao CV, Simi B, Wynn TT, Garr K, Reddy BS. Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res. 1996;56:532-537.
122. Hendrickse CW, Radley S, Donovan IA, Keighley MR, Neoptolemos JP. Activities of phospholipase A2 and diacylglycerol lipase are increased in human colorectal cancer. Br J Surg. 1995;82:475-478.
123. Tribler L, Jensen LT, Jorgensen K, etal. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue. Anticancer Res. 2007;27:3179-3185.
124. Praml C, Amler LC, Dihlmann S, Finke LH, Schlag P, Schwab M. Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa. Oncogene. 1998;17:2009-2012.
125. Tzotzas T, Filippatos TD, Triantos A, Bruckert E, Tselepis AD, Kiortsis DN. Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women. Nutr Metab Cardiovasc Dis. 2008;18:477-482.
126. Pedersen MW, Koenig W, Christensen JH, Schmidt EB. The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults. Eur J Nutr. 2009;48:1-5.
127. Vinson A, Mahaney MC, Diego VP, etal. Genotype-by-diet effects on co-variation in Lp-PLA2 activity and LDL-cholesterol concentration in baboons fed an atherogenic diet. J Lipid Res. 2008;49:1295-1302.
128. Yang P, Chan D, Felix E, etal. Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells. J Lipid Res. 2004;45:1030-1039.
129. Vanamala J, Glagolenko A, Yang P, etal. Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3. Carcinogenesis. 2008;29:790-796.
130. van Dijk AP, McCafferty DM, Wilson JH, Zijlstra FJ. 15-Hydroxy-eicosatetraenoic acid has minor anti-inflammatory properties in colitis. Agents Actions. 1993;38(Suppl 2):C120-C121.
131. Chen GG, Xu H, Lee JF, etal. 15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway. Int J Cancer. 2003;107:837-843.
132. Shureiqi I, Wojno KJ, Poore JA, etal. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis. 1999;20:1985-1995.
133. Smith WL, Meade EA, DeWitt DL. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann N Y Acad Sci. 1994;714:136-142.
134. DeRubertis FR, Craven PA, Saito R. Bile salt stimulation of colonic epithelial proliferation. Evidence for involvement of lipoxygenase products. J Clin Invest. 1984;74:1614-1624.
135. Lepage MG, Wargovich M, Smith TJ. Arachidonic acid metabolism in the Min mouse interstine: colon tumor 12-lipoxygenase and effect of green tea polyphenols. Proc Am Assoc Cancer Res. 2005;46. Available at:. Accessed 10 January 2011.
136. Bortuzzo C, Hanif R, Kashfi K, Staiano-Coico L, Shiff SJ, Rigas B. The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim Biophys Acta. 1996;1300:240-246.
137. Shimizu T, Suzuki M, Lee T, Igarashi J, Kaneko K, Yamashiro Y. Effects of n-3 polyunsaturated fatty acids on indomethacin-induced changes in eicosanoid production and blood flow in the gastric mucosa of rats. Prostaglandins Leukot Essent Fatty Acids. 2003;69:33-37.
138. Kurlandsky LE, Bennink MR, Webb PM, Ulrich PJ, Baer LJ. The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis. Pediatr Pulmonol. 1994;18:211-217.
139. Hall JA, Van Saun RJ, Wander RC. Dietary (n-3) fatty acids from menhaden fish oil alter plasma fatty acids and leukotriene B synthesis in healthy horses. J Vet Intern Med. 2004;18:871-879.
140. Surette ME, Koumenis IL, Edens MB, etal. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. Clin Ther. 2003;25:972-979.
141. Begum R, Belury MA, Burgess JR, Peck LW. Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients. J Ren Nutr. 2004;14:233-241.
142. Cleland LG, Gibson RA, Neumann MA, Hamazaki T, Akimoto K, James MJ. Dietary (n-9) eicosatrienoic acid from a cultured fungus inhibits leukotriene B4 synthesis in rats and the effect is modified by dietary linoleic acid. J Nutr. 1996;126:1534-1540.
143. Tanabe T, Tohnai N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat. 2002;68-69:95-114.
144. Manna C, D'Angelo S, Migliardi V, etal. Protective effect of the phenolic fraction from virgin olive oils against oxidative stress in human cells. J Agric Food Chem. 2002;50:6521-6526.
145. Braga C, La Vecchia C, Franceschi S, etal. Olive oil, other seasoning fats, and the risk of colorectal carcinoma. Cancer. 1998;82:448-453.
146. Palozza P, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Calviello G. β-Carotene downregulates the steady-state and heregulin-alpha-induced COX-2 pathways in colon cancer cells. J Nutr. 2005;135:129-136.
147. Manna C, Galletti P, Cucciolla V, Montedoro G, Zappia V. Olive oil hydroxytyrosol protects human erythrocytes against oxidative damages. J Nutr Biochem. 1999;10:159-165.
148. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H. Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignans and squalene. Food Chem Toxicol. 2000;38:647-659.
149. Visioli F, Galli C. Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr. 2002;42:209-221.
150. Menendez JA, Vellon L, Lupu R. Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells. Med Hypotheses. 2005;64:997-1001.
151. Vadlamudi R, Mandal M, Adam L, Steinbach G, Mendelsohn J, Kumar R. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene. 1999;18:305-314.
152. Half E, Broaddus R, Danenberg KD, Danenberg PV, Ayers GD, Sinicrope FA. HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors. Int J Cancer. 2004;108:540-548.
153. de la Puerta R, Ruiz Gutierrez V, Hoult JR. Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochem Pharmacol. 1999;57:445-449.
154. Petroni A, Blasevich M, Papini N, Salami M, Sala A, Galli C. Inhibition of leukocyte leukotriene B4 production by an olive oil-derived phenol identified by mass-spectrometry. Thromb Res. 1997;87:315-322.
155. Bogani P, Galli C, Villa M, Visioli F. Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis. 2007;190:181-186.
156. Hegazi RA, Saad RS, Mady H, Matarese LE, O'Keefe S, Kandil HM. Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-10 knockout mice. Nutrition. 2006;22:275-282.
157. Beauchamp GK, Keast RS, Morel D, etal. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005;437:45-46.
158. Murakami M, Kudo I. Prostaglandin E synthase: a novel drug target for inflammation and cancer. Curr Pharm Des. 2006;12:943-954.
159. Schade S, Bezugla Y, Kolada A, Kamionka S, Scheibe R, Dieter P. Diverse functional coupling of cyclooxygenase 1 and 2 with final prostanoid synthases in liver macrophages. Biochem Pharmacol. 2002;64:1227-1232.
160. St-Onge M, Flamand N, Biarc J, etal. Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils. Biochim Biophys Acta. 2007;1771:1235-1245.
161. Nakanishi M, Montrose DC, Clark P, etal. Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res. 2008;68:3251-3259.
162. Elander N, Ungerback J, Olsson H, Uematsu S, Akira S, Soderkvist P. Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC(Min/+) mice. Biochem Biophys Res Commun. 2008;372:249-253. Epub 2008 May 15.
163. Subbaramaiah K, Yoshimatsu K, Scherl E, etal. Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1. J Biol Chem. 2004;279:12647-12658.
164. Yoshimatsu K, Golijanin D, Paty PB, etal. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin Cancer Res. 2001;7:3971-3976.
165. Sanchez-Fidalgo S, Cardeno A, Villegas I, Talero E, de la Lastra CA. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol. 2010;633:78-84.
166. Poole EM, Hsu L, Xiao L, etal. Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2010;19:547-557.
167. Paniagua JA, de la Sacristana AG, Sanchez E, etal. A MUFA-rich diet improves postprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr. 2007;26:434-444.
168. Vessby B, Uusitupa M, Hermansen K, etal. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia. 2001;44:312-319.
169. de Lorgeril M, Salen P, Martin JL, Monjaud I, Boucher P, Mamelle N. Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Arch Intern Med. 1998;158:1181-1187.
170. Lairon D. Intervention studies on Mediterranean diet and cardiovascular risk. Mol Nutr Food Res. 2007;51:1209-1214.
171. Estruch R, Martinez-Gonzalez MA, Corella D, etal. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145:1-11.
172. Salas-Salvado J, Bullo M, Babio N, etal. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care. 2010;34:14-19.
173. Djuric Z, Ren J, Blythe J, VanLoon G, Sen A. A Mediterranean dietary intervention in healthy American women changes plasma carotenoids and fatty acids in distinct clusters. Nutr Res. 2009;29:156-163.
174. Djuric Z, Vanloon G, Radakovich K, Dilaura NM, Heilbrun LK, Sen A. Design of a Mediterranean exchange list diet implemented by telephone counseling. J Am Diet Assoc. 2008;108:2059-2065.
175. Vincent-Baudry S, Defoort C, Gerber M, etal. The Medi-RIVAGE study: reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am J Clin Nutr. 2005;82:964-971.
176. Field CJ, Angel A, Clandinin MT. Relationship of diet to the fatty acid composition of human adipose tissue structural and stored lipids. Am J Clin Nutr. 1985;42:1206-1220.
177. Due A, Larsen TM, Mu H, Hermansen K, Stender S, Astrup A. Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr. 2008;88:1232-1241.
178. McMurchie EJ, Margetts BM, Beilin LJ, Croft KD, Vandongen R, Armstrong BK. Dietary-induced changes in the fatty acid composition of human cheek cell phospholipids: correlation with changes in the dietary polyunsaturated/saturated fat ratio. Am J Clin Nutr. 1984;39:975-980.
179. Bagga D, Capone S, Wang HJ, etal. Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst. 1997;89:1123-1131.
180. Hillier K, Jewell R, Dorrell L, Smith CL. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut. 1991;32:1151-1155.
181. Buhner S, Nagel E, Korber J, Vogelsang H, Linn T, Pichlmayr R. Ileal and colonic fatty acid profiles in patients with active Crohn's disease. Gut. 1994;35:1424-1428.
182. Nishida T, Miwa H, Shigematsu A, Yamamoto M, Iida M, Fujishima M. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut. 1987;28:1002-1007.
183. Pacheco S, Hillier K, Smith C. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease. Clin Sci (Lond). 1987;73:361-364.
184. Shim YJ, Choi KY, Lee WC, Kim MK, Lee SY, Lee-Kim YC. Phospholipid fatty acid patterns in the mucosa of human colorectal adenomas and carcinomas. Nutr Res. 2005;25:261-269.
185. Fernandez-Banares F, Esteve M, Navarro E, etal. Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence. Gut. 1996;38:254-259.
186. Szachowicz-Petelska B, Sulkowski S, Figaszewski ZA. Altered membrane free unsaturated fatty acid composition in human colorectal cancer tissue. Mol Cell Biochem. 2007;294:237-242.
187. Drew JE, Padidar S, Horgan G, etal. Salicylate modulates oxidative stress in the rat colon: a proteomic approach. Biochem Pharmacol. 2006;72:204-216.
188. Murugan RS, Mohan KV, Uchida K, Hara Y, Prathiba D, Nagini S. Modulatory effects of black tea polyphenols on oxidant-antioxidant profile and expression of proliferation, apoptosis, and angiogenesis-associated proteins in the rat forestomach carcinogenesis model. J Gastroenterol. 2007;42:352-361.
189. Fuchs D, Vafeiadou K, Hall WL, etal. Proteomic biomarkers of peripheral blood mononuclear cells obtained from postmenopausal women undergoing an intervention with soy isoflavones. Am J Clin Nutr. 2007;86:1369-1375.
190. Delage B, Bairras C, Buaud B, Pallet V, Cassand P. A high-fat diet generates alterations in nuclear receptor expression: prevention by vitamin A and links with cyclooxygenase-2 and beta-catenin. Int J Cancer. 2005;116:839-846.
191. Delage B, Rullier A, Capdepont M, Rullier E, Cassand P. The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers. Nutr J. 2007;6:20.
192. Tabibiazar R, Wagner RA, Deng A, Tsao PS, Quertermous T. Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice. Physiol Genomics. 2006;25:194-202.
193. Habermann JK, Paulsen U, Roblick UJ, etal. Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer. 2007;46:10-26.
194. Rho JH, Qin S, Wang JY, Roehrl MH. Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer. J Proteome Res. 2008;7:2959-2972.
195. Hsieh SY, Shih TC, Yeh CY, Lin CJ, Chou YY, Lee YS. Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics. 2006;6:5322-5331.
196. Alrawi SJ, Schiff M, Carroll RE, etal. Aberrant crypt foci. Anticancer Res. 2006;26:107-119.
197. Wada M, DeLong CJ, Hong YH, etal. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem. 2007;282:22254-22266.
198. Evans JF, Nathaniel DJ, Zamboni RJ, Ford-Hutchinson AW. Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolase. J Biol Chem. 1985;260:10966-10970.
199. James MJ, Gibson RA, Neumann MA, Cleland LG. Effect of dietary supplementation with n-9 eicosatrienoic acid on leukotriene B4 synthesis in rats: a novel approach to inhibition of eicosanoid synthesis. J Exp Med. 1993;178:2261-2265.
200. Urquiaga I, Guasch V, Marshall G, etal. Effect of Mediterranean and Occidental diets, and red wine, on plasma fatty acids in humans. An intervention study. Biol Res. 2004;37:253-261.
201. Zazpe I, Sanchez-Tainta A, Estruch R, etal. A large randomized individual and group intervention conducted by registered dietitians increased adherence to Mediterranean-type diets: the PREDIMED study. J Am Diet Assoc. 2008;108:1134-1144; discussion 1145.